Pioneering Research in Mucosa Health
Focusing on mucosa role in mitigating cancer treatment toxicity, improving women’s health, and addressing dysbiosis-mediated conditions.
Cancer Therapy Support
Addressing mucosal toxicity in oncology treatments
Women’s Health Innovating in urogenital mucosa wellbeing in menopause and breast cancer survivors
Human Microbiome
Restoring balance at the interface of host-immunity and microbial ecosystems, reducing inflamation
Our mission aligns with the demands of longer life expectancy, rising chronic conditions, and an urgent need for preventive, patient-centered care, building a future where mucosa and microbiome health is recognized as foundational to systemic wellbeing.
Our research focuses on mucosal and skin integrity, supporting vulnerable groups such as cancer patients undergoing chemo or radiotherapy, women facing mucosal challenges across life stages, and individuals needing microbiome restoration to reduce inflammatory burden.
Providing safe and effective, evidence-based solutions for oral mucositis to improve patient comfort and compliance.
Providing safe and effective estrogen-free solutions with the highest level of evidence for menopausal women and breast cancer survivors.
Providing safe and effective solutions aimed at modulating local microbiome and host immune response to attenuate pro-inflammatory cytokine release and enhance physiological pathways.
Mucosa Innovations is a research-driven biotechnology company pioneering novel approaches to enhance mucosa and skin health, and to restore microbiome–host immune response addressing some of today’s most pressing health challenges.
Aiming to set the new gold standard with safe and effective solutions.
Mucosa innovations is led by a multidisciplinary team, that brings together decades of experience in clinical practice, patient-centered medical innovation, academic research and strategic leadership to drive a new frontier in Microbiome and Mucosa and Skin health.
The Founding Team
Beatriz Rodríguez-Vilaboa
Medical Science Liaison (MSL)
Accomplishment
5
Clinical trials declared
at clinical trial.gov
7
Protocols
under development
5
Solutions ready for
regulatory submission
Jorge Rodriguez-Vilaboa
CEO
Jorge holds a dual degree in Law and Economics, with extensive experience in international legal practice and entrepreneurship in the health and life sciences sector.
Débora Rodríguez-Vilaboa CSO
With a long-standing medical career, she is the author of international patents in health technologies and has led R&D initiatives across multiple medical fields.
Beatriz Rodríguez-Vilaboa Medical Science Liaison (MSL)
Holds a PhD in Medicine and complements her academic foundation with executive training from IESE Business School. With a long-standing career in the field, she combines clinical expertise, research and entrepreneurial insight.